PROBE parallel group 6 wk treatment comparing telmisartan + HCT [Hydrochlorothiazide] (40/12.5mg, or 80/12.5mg) with losartan + HCT (50/12.5mg) using ABPM [ambulatory blood pressure monitoring] in Pts [patients] with mild-to moderate hypertension.

Trial Profile

PROBE parallel group 6 wk treatment comparing telmisartan + HCT [Hydrochlorothiazide] (40/12.5mg, or 80/12.5mg) with losartan + HCT (50/12.5mg) using ABPM [ambulatory blood pressure monitoring] in Pts [patients] with mild-to moderate hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2009

At a glance

  • Drugs Losartan/hydrochlorothiazide; Telmisartan/hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 28 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top